Lack of evidence for direct involvement of NMDA receptors or polyamines in blood-brain barrier injury after cerebral ischemia in rats

Brain Research

Volumn 813, Issue 1, 1998, Pages 191-194

  Preston, Edward ^a   Webster, Jacqueline ^a   Palmer, Gene C ^b  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b Astra Arcus USA   (United States)

Author keywords

Blood brain barrier; Cerebral ischemia; NMDA receptor; Polyamines

Indexed keywords

DIZOCILPINE; EFLORNITHINE; LANICEMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; POLYAMINE; PUTRESCINE; SUCROSE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CONTROLLED STUDY; MALE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; RAT; SYNTHESIS;

ANIMALS; BIOGENIC POLYAMINES; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; DIZOCILPINE MALEATE; EFLORNITHINE; EXCITATORY AMINO ACID ANTAGONISTS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0032583237     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00981-0     Document Type: Article

References (25)

1. Beart P.M., Sheehan K.-A.M., Manallack D.T. Absence of N-methyl-D-aspartate receptors on ovine cerebral microvessels. J. Cereb. Blood Flow Metab. 8:1988;879-882.
2. Buchan A., Pulsinelli W.A. Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J. Neurosci. 10:1990;311-316.
3. Cregan E.F., Peeling J., Corbett D., Buchan A.M., Saunders J., Auer R.N., Gao M., McCarthy D.J., Eisman M.S., Campbell T.M., Murray R.J., Stagnitto M.L., Palmer G.C. (S)-Alpha-phenyl-2-pyridine-ethanamine dihydrochloride], a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemia. J. Pharmacol. Exp. Ther. 283:1997;1412-1424.
4. Corbett D., Evans S., Thomas C., Wang D., Jonas R.A. MK-801 reduced cerebral ischemic injury by inducing hypothermia. Brain Res. 514:1990;300-304.
5. Gjedde A. High- and low-affinity transport of D-glucose from blood to brain. J. Neurochem. 36:1981;1463-1471.
6. Hatfield R.H., Gill R., Brazell C. The dose relationship and therapeutic window for dizocilpine (MK-801) in a rat focal ischaemia model. Eur. J. Pharmacol. 216:1992;1-7.
7. C.Y. Hsu, T.H. Liu, J. Xu, E.L. Hogan, J. Chao, Lipid inflammatory mediators in ischemic brain edema and injury, in: N.G. Bazan (Ed.), Lipid Mediators in Ischemic Brain Damage and Experimental Epilepsy, New Trends Lipid Mediators Research, Vol. 4, Karger, Basel, 1990, pp. 85-112.
8. I. Klatzo, Concepts of ischemic injury associated with brain edema, in: Y. Inaba, I. Klatzo, M. Spatz (Eds.), Brain Edema, Springer, Tokyo, 1984, pp. 1-5.
9. Koenig H., Goldstone A.D., Lu C.Y., Trout J.J. Brain polyamines are controlled by N-methyl-D-aspartate receptors during ischemia and recirculation. Stroke. 21(III):1990;98-102.
10. Koenig H., Trout J.J., Goldstone A.D., Lu C.Y. Capillary NMDA receptors regulate blood-brain barrier function and breakdown. Brain Res. 588:1992;297-303.
11. Lin B., Dietrich W.D., Ginsberg M.D., Globus M.Y.-T., Busto R. MK-801 (Dizocilpine) protects the brain from repeated normothermic global ischemic insults in the rat. J. Cereb. Blood Flow Metab. 13:1993;925-932.
12. Mayhan W.G., Didion S.P. Glutamate-induced disruption of the blood-brain barrier in rats. Stroke. 27:1996;965-970.
13. Morley P., Small D.L., Murray C.L., Mealing G.A., Poulter M.O., Durkin J.P., Stanimirovic D.B. Evidence that functional glutamate receptors are not expressed on rat or human cerebromicrovascular endothelial cells. J. Cereb. Blood Flow Metab. 18:1998;396-406.
14. Muszynski C.A., Robertson C.S., Goodman J.C., Henley C.M. DFMO reduces cortical infarct volume after middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 13:1993;1033-1037.
15. Nellgard B., Gustafson I., Wieloch T. Lack of protection by the N-methyl-D-aspartate receptor blocker dizocilpine (MK-801) after transient severe cerebral ischemia in the rat. Anesthesiology. 75:1991;279-287.
16. Paschen W., Rohn G., Meese C.O., Djuricic B., Schmidt-Kastner R. Polyamine metabolism in reversible cerebral ischemia: effect of α-difluoromethylornithine. Brain Res. 453:1988;9-16.
17. Patlak C.S., Blasberg R.G., Fenstermacher J.D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 3:1983;1-7.
18. Preston E., Foster D.O. Evidence for pore-like opening of the blood-brain barrier following forebrain ischemia in rats. Brain Res. 761:1997;4-10.
19. 3H -sucrose following forebrain ischaemia in the rat Acta Neurochir. S. 51:1990;174-176.
20. Preston E., Sutherland G., Finsten A. Three openings of the blood-brain barrier produced by forebrain ischemia in the rat. Neurosci. Lett. 149:1993;75-78.
21. Rao A.M., Baskaya M.K., Maley M.E., Prasad M.R., Dempsey R.J. Ornithine decarboxylase activity and edema formation in cerebral ischemia of conscious gerbils. J. Neurochem. 65:1995;2639-2643.
22. Schmitz M.P., Combs D.J., Dempsey R.J. Difluoromethylornithine decreases postischemic brain edema and blood-brain barrier breakdown. Neurosurgery. 33:1993;882-888.
23. Smith M.L., Auer R.N., Siesjo B.K. The density and distribution of ischemic brain injury in the rat following 2-10 min of forebrain ischemia. Acta Neuropathol. 64:1984;319-332.
24. Wahl M., Schilling L., Unterberg A., Baethmann A. Mediators of vascular and parenchymal mechanisms in secondary brain damage. Acta Neurochir. S57:1993;64-72.
25. Wei L., Otsuka T., Acuff V., Bereczki D., Pettigrew K., Patlak C., Fenstermacher J. The velocities of red cell and plasma flows through parenchymal microvessels of rat brain are decreased by pentobarbital. J. Cereb. Blood Flow Metab. 13:1993;487-497.